The effects of portable, exertional oxygen in chronic obstructive pulmonary disease.

A randomised, double-blinded, controlled trial to evaluate the effects of portable, exertional oxygen upon dyspnoea, quality of life and exercise tolerance in chronic obstructive pulmonary disease

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12605000457640

Enrollment

160

Registered

2005-09-22

Start date

2004-05-08

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This project aims to investigate the effects of portable oxygen, used during activity, by people who have chronic obstructive pulmonary disease.

Interventions

Subjects who have COPD but are not severely hypoxaemic at rest are randomised to receive either portable, compressed oxygen or portable compressed air to use during exertional activities for a period of 12 weeks.

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Treatment

Masking

Blinded (masking used)

Eligibility

Sex/Gender

All

Age

0 to No maximum

Healthy volunteers

Inclusion criteria

Diagnosis of chronic obstructive pulmonary disease, non-smoker, activity limited by breathlessness, clinically stable for previous 4 weeks, does not qualify for long term oxygen therapy (PaO2 > 55 mmHg), not currently receiving home oxygen therapy.

Exclusion criteria

Significant locomotor disability, other severe disabling medical condition, currently attending a Pulmonary Rehabilitation Program.

Outcome results